Detalles de la búsqueda
1.
Associations between missing teeth and the risk of cancer in Korea: a nationwide cohort study.
BMC Oral Health
; 23(1): 418, 2023 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37353779
2.
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancer.
Int J Cancer
; 2021 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905134
3.
Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13).
Cytokine
; 142: 155487, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33770643
4.
Genome-wide association study of genetic variants related to anthracycline-induced cardiotoxicity in early breast cancer.
Cancer Sci
; 111(7): 2579-2587, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32378780
5.
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer.
Oncologist
; 25(9): e1346-e1354, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536013
6.
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients.
Breast Cancer Res Treat
; 182(2): 333-343, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32468335
7.
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 20(12): 1750-1759, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31668850
8.
Integrative molecular profiling identifies a novel cluster of estrogen receptor-positive breast cancer in very young women.
Cancer Sci
; 110(5): 1760-1770, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30811755
9.
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16).
Br J Cancer
; 121(12): 985-990, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690831
10.
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
Ann Surg Oncol
; 26(8): 2409-2416, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31065958
11.
A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial.
Int J Cancer
; 143(12): 3240-3247, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29978467
12.
Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer.
Breast Cancer Res Treat
; 172(2): 425-436, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30132218
13.
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
Breast Cancer Res Treat
; 170(1): 69-76, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29516374
14.
Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea.
Oncology
; 91(5): 274-282, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27623006
15.
A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09.
Support Care Cancer
; 24(4): 1709-17, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26423618
16.
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).
Breast Cancer Res Treat
; 152(1): 77-85, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033708
17.
Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
Breast Cancer Res Treat
; 148(1): 91-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25253173
18.
High volumetric breast density predicts risk for breast cancer in postmenopausal, but not premenopausal, Korean Women.
Ann Surg Oncol
; 21(13): 4124-32, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24934582
19.
Comparison of sentinel lymph node biopsy guided by the multimodal method of indocyanine green fluorescence, radioisotope, and blue dye versus the radioisotope method in breast cancer: a randomized controlled trial.
Ann Surg Oncol
; 21(4): 1254-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24356798
20.
Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer.
Tumour Biol
; 35(12): 12173-80, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25179838